Loading
Total declarations
Company
▲ Purchases (1 ops.)
▼ Sales (0 ops.)
Latest filing published 14 Sept 2023 for Panbela Therapeutics, Inc.. Read the official filing
Insider track record
Disclosed buys
1
Disclosed sells
0
Signal history
No signal scores available.
Closed purchases
Market purchases
1
Not enough history yet: 0 closed purchases, at least 2 are needed.
Purchases by company
Jeffrey E. Jacob: trading record in brief
Jeffrey E. Jacob discloses dealings in Panbela Therapeutics, Inc. to SEC (Form 4). We count 2 filings; the first trade dates from 4 October 2022 and the latest from 12 September 2023.
Every open-market trade on record is a purchase: 1 purchase, and no sale. The totals do not cover 1 filing with an undisclosed amount. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket.
The record was last updated on 14 September 2023 with a transaction in Panbela Therapeutics, Inc. The most recent open-market purchase was published on 6 October 2022, 1,473 days ago. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Companies and markets linked to Jeffrey E. Jacob
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations2 total
275 shares0Common StockSEC:0001437749-23-025900:0
33,000 sharesCommon StockSEC:0001437749-22-023772:0
Canonical exit: 2 Jan 2023 (T+90)
2 of 2 declarations
